Reporting Quality Assessment of COVID-19 Clinical Trials in China at the beginning of the Pandemic: An Empirical Study based on the CONSORT Statement

Journal Title: Medical Journal of Clinical Trials & Case Studies - Year 2021, Vol 5, Issue 1

Abstract

Objectives: This study aimed to evaluate the reporting quality and risk of bias of Chinese COVID-19 RCTs. Methods: The Chinese clinical trial registry (ChiCTR) was searched for registered COVID-19 clinical trials before April 2, 2020. The reporting quality and risk of bias of included literatures were assessed using the Consolidating Standards of Reporting Trials 2010 (CONSORT 2010) and Cochrane risk of bias tool, respectively. Results: Of the 283 clinical trials identified, 172 RCTs were included. Some items including objectives, trial design, participants, interventions, outcomes and registration were presented in all RCTs, other items in limited RCTs, including blinding (11.63%), allocation concealment mechanism (14.53%), implementation (47.09%), title/abstract (54.07%), protocol (94.77%), sequence generation (97.09%), and funding (98.84%). The top three score among 25-item were background and objectives (10.00), registration (10.00) and funding (9.90), while the lowest four score all belonged to randomization part, including blinding (0.59), allocation concealment mechanism (0.88), implementation (1.43) and sequence generation (2.71). Among the RCTs, 75.58% showed low risk of bias in random sequence generation, while only 9.30% low risk of bias in allocation concealment. Besides, 39.53% presented with high performance bias and detection bias. Conclusions: The reporting quality of RCTs registered on the ChiCTR was significantly lower than expected, especially in randomization and blinding. Researchers are advised to refer to the CONSORT statement when designing a RCT.

Authors and Affiliations

Cui Z , Zhang Z , Bai Q and Bian Y*

Keywords

Related Articles

Gastric Cancer During Pregnancy; Torsion of Krukenberg Tumor (KT)

Ovarian tumor is very rare in pregnant women and only 5% of them are malignant and most of them appear as Krukenberg tumors (KT). The most common complication of ovarian tumors encountered in pregnancy is torsion. In th...

Attitude and Behavior of Emerging Novel COVID-19 Disease Khartoum, Sudan

Background: The emerging COVID-19 is a devastating life-threatening disease, which is characterized by high morbidity. More than 40 million people have been affected globally with case fatality rate ranging between 5 – 1...

Techniques for Writing Chapter I of Research and Development in Public Health

Outline of Chapter I in general research consists of title, introduction, research questions, purpose statements, hypothesis, scopes of research, definitions, and benefits which research and development in public health...

The Effects of Eating Habits and Physical Activity on Obesity

Obesity is the most important public health problem all around the world. According to the epidemiological studies, socio-cultural and demographic factors and also biological factors can cause the obesity. Obesity has b...

Nadir and Finical Minimally Invasive Adenocarcinoma Lung

Minimally invasive adenocarcinoma emerges as a miniature, solitary, localized, primary pulmonary adenocarcinoma ≤ 3.0 centimetre magnitude and ≤ 0.5 centimetre zone of stromal invasion or non-invasive (lepidic) pattern o...

Download PDF file
  • EP ID EP756400
  • DOI 10.23880/mjccs-16000S1-010
  • Views 22
  • Downloads 0

How To Cite

Cui Z, Zhang Z, Bai Q and Bian Y* (2021). Reporting Quality Assessment of COVID-19 Clinical Trials in China at the beginning of the Pandemic: An Empirical Study based on the CONSORT Statement. Medical Journal of Clinical Trials & Case Studies, 5(1), -. https://www.europub.co.uk/articles/-A-756400